Bgm (BGM) Non-Current Assets (2019 - 2025)

Bgm's (BGM) quarterly Non-Current Assets came in at $382.3 million in Q3 2025, up 21911.37% year-on-year from N/an in Q3 2024, and up 132.45% on a QoQ basis from $164.5 million in Q1 2025.

Bgm (BGM) Non-Current Assets (2019 - 2025) Analysis & Trends

Bgm (BGM) has 7 years of Non-Current Assets data on file, last reported at $382.3 million in Q3 2025.

  • On a quarterly basis, Non-Current Assets rose 21911.37% year-over-year to $382.3 million in Q3 2025; TTM through Sep 2025 was -$27078.7 billion, a 1559220761.62% decrease from a year earlier, with the FY2025 full-year figure at $382.3 million, up 21911.37% from the prior year.
  • Non-Current Assets for Q3 2025 stood at $382.3 million, up from $164.5 million in the prior quarter.
  • Over the last five years, Non-Current Assets for BGM reached as high as $382.3 million in Q3 2025 and fell as low as -$58505.6 billion in Q1 2021.
  • Historically, Non-Current Assets has averaged -$12852.1 billion across 5 years, with a median of $9.1 million in 2024.
  • Across the five-year window, Non-Current Assets plunged 95.69% in 2023 and soared 21911.37% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $35.0 million in 2021, then decreased by 1.42% to $34.5 million in 2022, then plunged by 95.69% to $1.5 million in 2023, then increased by 16.88% to $1.7 million in 2024, then surged by 21911.37% to $382.3 million in 2025.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $382.3 million in Q3 2025, $164.5 million in Q1 2025, and $1.7 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 26.33 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 3.84 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - 18.82 Mn
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 9.64 Bn
10 Bgm 33.55 Mn 23.73 Mn - 382.27 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 382.27 Mn
Mar 31, 2025 164.45 Mn
Sep 30, 2024 1.74 Mn
Mar 31, 2024 16.53 Mn
Sep 30, 2023 1.49 Mn
Mar 31, 2023 -27,079.30 Bn
Sep 30, 2022 34.49 Mn
Mar 31, 2022 -42,936.45 Bn
Sep 30, 2021 34.99 Mn
Mar 31, 2021 -58,505.61 Bn
Sep 30, 2020 10.63 Mn
Sep 30, 2019 10.30 Mn